These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 7689205

  • 1. Oral flecainide, sotalol, and verapamil for the termination of paroxysmal supraventricular tachycardia.
    Hamer AW, Strathmore N, Vohra JK, Hunt VD.
    Pacing Clin Electrophysiol; 1993 Jul; 16(7 Pt 1):1394-400. PubMed ID: 7689205
    [Abstract] [Full Text] [Related]

  • 2. Flecainide and sotalol: a new combination therapy for refractory supraventricular tachycardia in children <1 year of age.
    Price JF, Kertesz NJ, Snyder CS, Friedman RA, Fenrich AL.
    J Am Coll Cardiol; 2002 Feb 06; 39(3):517-20. PubMed ID: 11823091
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Failure of episodic high-dose oral verapamil therapy to convert supraventricular tachycardia: a study of plasma verapamil levels and gastric motility.
    Hamer AW, Tanasescu DE, Marks JW, Peter T, Waxman AD, Mandel WJ.
    Am Heart J; 1987 Aug 06; 114(2):334-42. PubMed ID: 3604891
    [Abstract] [Full Text] [Related]

  • 5. Effective termination of reentrant supraventricular tachycardia by single dose oral combination therapy with pindolol and verapamil.
    Rose JS, Bhandari A, Rahimtoola SH, Wu D.
    Am Heart J; 1986 Oct 06; 112(4):759-65. PubMed ID: 3766376
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of out-of-hospital self-administered single-dose oral drug treatment in the management of infrequent, well-tolerated paroxysmal supraventricular tachycardia.
    Alboni P, Tomasi C, Menozzi C, Bottoni N, Paparella N, Fucà G, Brignole M, Cappato R.
    J Am Coll Cardiol; 2001 Feb 06; 37(2):548-53. PubMed ID: 11216977
    [Abstract] [Full Text] [Related]

  • 7. Comparison of transplacental treatment of fetal supraventricular tachyarrhythmias with digoxin, flecainide, and sotalol: results of a nonrandomized multicenter study.
    Jaeggi ET, Carvalho JS, De Groot E, Api O, Clur SA, Rammeloo L, McCrindle BW, Ryan G, Manlhiot C, Blom NA.
    Circulation; 2011 Oct 18; 124(16):1747-54. PubMed ID: 21931080
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Flecainide as first-line treatment for supraventricular tachycardia in newborns.
    Ferlini M, Colli AM, Bonanomi C, Salvini L, Galli MA, Salice P, Ravaglia R, Centola M, Danzi GB.
    J Cardiovasc Med (Hagerstown); 2009 May 18; 10(5):372-5. PubMed ID: 19300276
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A randomized comparison of flecainide versus verapamil in paroxysmal supraventricular tachycardia. The Flecainide Multicenter Investigators Group.
    Dorian P, Naccarelli GV, Coumel P, Hohnloser SH, Maser MJ.
    Am J Cardiol; 1996 Jan 25; 77(3):89A-95A. PubMed ID: 8607397
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT, Voon WC, Yen HW, Chang JS, Sheu SH, Hwang YS, Chiu HF.
    Am J Cardiol; 1993 Feb 15; 71(5):405-8. PubMed ID: 8430627
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sotalol as first-line treatment for fetal tachycardia and neonatal follow-up.
    van der Heijden LB, Oudijk MA, Manten GT, ter Heide H, Pistorius L, Freund MW.
    Ultrasound Obstet Gynecol; 2013 Sep 15; 42(3):285-93. PubMed ID: 23303470
    [Abstract] [Full Text] [Related]

  • 16. Intravenous flecainide acetate for supraventricular tachycardias.
    Hellestrand KJ.
    Am J Cardiol; 1988 Aug 25; 62(6):16D-22D. PubMed ID: 3136630
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia.
    Rinkenberger RL, Naccarelli GV, Berns E, Dougherty AH.
    Am J Cardiol; 1988 Aug 25; 62(6):44D-55D. PubMed ID: 3136636
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy, safety, and tolerance of d-sotalol in patients with refractory supraventricular tachyarrhythmias.
    Sahar DI, Reiffel JA, Bigger JT, Squatrito A, Kidwell GA.
    Am Heart J; 1989 Mar 25; 117(3):562-8. PubMed ID: 2919535
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.